» Articles » PMID: 21242893

Hematopoietic Stem/precursor Cells As HIV Reservoirs

Overview
Date 2011 Jan 19
PMID 21242893
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Although latent HIV-1 infection in CD4+ T cells contributes to HIV persistence, there is mounting evidence that other viral reservoirs exist. Here, we review recent data suggesting that the infection of hematopoietic progenitor cells creates additional reservoirs for HIV in vivo.

Recent Findings: New studies suggest that some types of hematopoietic progenitor cells have the potential to generate reservoirs for HIV. This review focuses on two types that can be infected by HIV in vitro and in vivo: multipotent hematopoietic progenitor cells in the bone marrow and circulating mast cell progenitors. Of these two types, only CD34+ bone marrow cells have been shown to harbor latent provirus in HIV-positive individuals with undetectable viral loads on highly active antiretroviral therapy (HAART). Latent infection of these long-lived cell types may create a significant barrier to HIV eradication; the infection of hematopoietic stem cells in particular could lead to an HIV reservoir that does not appreciably decay over the lifespan of the host.

Summary: To eradicate HIV infection, it will be necessary to purge all viral reservoirs in the host. The findings highlighted here suggest that multipotent hematopoietic progenitor cells and possibly tissue mast cells may constitute significant reservoirs for HIV that must be addressed in order to eliminate HIV infection. Future studies are needed to determine which types of CD34+ cells are infected in vivo and whether infected CD34+ cells contribute to residual viremia in people with undetectable viral loads on HAART.

Citing Articles

Associated factors and prognostic implications of neutropenia in individuals with HIV/AIDS.

Li P, Lv X, Shen H, Fang J, Wei M, Liu X Virol J. 2025; 22(1):6.

PMID: 39789626 PMC: 11721557. DOI: 10.1186/s12985-025-02624-x.


Recognition of HIV-1-infected fibrocytes lacking Nef-mediated HLA-B downregulation by HIV-1-specific T cells.

Kuse N, Noyori O, Takahashi N, Zhang Y, Suzu S, Takiguchi M J Virol. 2024; 98(7):e0079124.

PMID: 38940584 PMC: 11264601. DOI: 10.1128/jvi.00791-24.


Mechanisms and Cardiorenal Complications of Chronic Anemia in People with HIV.

Kamvuma K, Hamooya B, Munsaka S, Masenga S, Kirabo A Viruses. 2024; 16(4).

PMID: 38675885 PMC: 11053456. DOI: 10.3390/v16040542.


HIV-1 proviral DNA in purified peripheral blood CD34 stem and progenitor cells in individuals with long-term HAART; paving the way to HIV gene therapy.

Tassaneetrithep B, Phuphuakrat A, Pasomsub E, Bhukhai K, Wongkummool W, Priengprom T Heliyon. 2024; 10(4):e26613.

PMID: 38434025 PMC: 10906414. DOI: 10.1016/j.heliyon.2024.e26613.


Chronic LCMV infection regulates the effector T cell response by inducing the generation of less immunogenic dendritic cells.

Yoo S, Jeong Y, Choi H, Chae S, Hwang D, Shin S Exp Mol Med. 2023; 55(5):999-1012.

PMID: 37121977 PMC: 10238507. DOI: 10.1038/s12276-023-00991-5.


References
1.
Redd A, Avalos A, Phiri K, Essex M . Effects of HIV type 1 infection on hematopoiesis in Botswana. AIDS Res Hum Retroviruses. 2007; 23(8):996-1003. DOI: 10.1089/aid.2006.0283. View

2.
North T, Higgins J, Deere J, Hayes T, Villalobos A, Adamson L . Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS. J Virol. 2009; 84(6):2913-22. PMC: 2826073. DOI: 10.1128/JVI.02356-09. View

3.
Brennan T, Woods J, Sedaghat A, Siliciano J, Siliciano R, Wilke C . Analysis of human immunodeficiency virus type 1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. J Virol. 2009; 83(17):8470-81. PMC: 2738142. DOI: 10.1128/JVI.02568-08. View

4.
Ramratnam B, Mittler J, Zhang L, Boden D, Hurley A, Fang F . The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med. 1999; 6(1):82-5. DOI: 10.1038/71577. View

5.
Yin A, Miraglia S, Zanjani E, Almeida-Porada G, Ogawa M, Leary A . AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1998; 90(12):5002-12. View